Mallinckrodt's EBIT per Share for the
three
months ended in Mar. 2024 was $-0.37.
Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-122.68.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Mallinckrodt's EBIT per Share or its related term are showing as below:
During the past 12 years, the highest 3-Year average EBIT per Share Growth Rate of Mallinckrodt was 55.40% per year. The lowest was -27.80% per year. And the median was -7.20% per year.
MCKPF's 3-Year EBIT Growth Rate is not ranked *
in the Drug Manufacturers industry.
Industry Median: 7.3 * Ranked among companies with meaningful 3-Year EBIT Growth Rate only.
Mallinckrodt's EBIT for the
three
months ended in Mar. 2024 was $-7 Mil.
Mallinckrodt EBIT per Share Historical Data
The historical data trend for Mallinckrodt's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-122.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Mallinckrodt (OTCPK:MCKPF) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Mallinckrodt EBIT per Share Related Terms
Thank you for viewing the detailed overview of Mallinckrodt's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.
Mallinckrodt PLC develops, manufactures, markets, and distributes specialty pharmaceutical products and therapies. Its areas of focus include autoimmune and rare diseases in specialty areas like neurology, rheumatology, nephrology, pulmonology and ophthalmology; immunotherapy and neonatal respiratory critical care therapies; analgesics and gastrointestinal products. The company operates its business in two reportable segments namely Specialty Brands which include specialty pharmaceutical brands; and Specialty Generics which includes niche specialty generic drugs and active pharmaceutical ingredients. It generates maximum revenue from the Specialty Brands segment. Geographically, it derives a majority of its revenue from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
MCKPF has been successfully added to your 